Let’s Talk About…
A Webinar Series
Launched in 2024, NCAAR’s Let’s Talk About… operates in collaboration with partner organizations to strengthen advocacy efforts, promote recovery from substance use disorder, support mental health, and expand access to community-centered education.
Hosted by Tonia Ahern, NCAAR’s Community Coordinator, the series has explored impactful topics from fentanyl awareness to substance-use-related would care in New Jersey. Let’s Talk About… brings together friends, colleagues, and community partners to spark meaningful conversations about the issues that matter most to us and the communities we serve.
On September 20, 2024, NCAAR presented Let’s Talk About…The Wounded Approach to Wound Care in New Jersey, an educational webinar about the barriers faced by those seeking medical care for substance use related wounds in partnership with Dr. Alexis LaPietra from RWJBarnabas Institute for Prevention and Recovery, and Mike Santillo from Prevention Links and the New Jersey Coalition for Addiction Recovery Support (NJ-CARS). The conversation focused on the challenges and efforts around providing integrated care and the state’s initiatives to revise regulations and licensing to achieve this goal.
In honor of Fentanyl Awareness Day on May 7th, NCAAR gathered a panel to break through the silos between prevention, family education, and recovery communities to provide a multi-faceted approach to the fentanyl crisis. NCAAR was joined by the Governor’s Council on Substance Use Disorder, Fred Muench, PhD, Former President of Partnership to End Addiction, and Partnership for a Drug-Free New Jersey, and Song for Charlie.
Presented by NCAAR in partnership with New Jersey Harm Reduction Coalition, ALCU of New Jersey, South Jersey AIDS Alliance, and the New Jersey Department of Health, Let’s Talk About…Harm Reduction Supplies: What You Need to Know About New Jersey’s New Law explores legislative session 2022-2023 bill S3957/A5630 which was signed into law by Governor Murphy on January 8, 2024 to expand exemptions from drug paraphernalia laws to certain harm reduction supplies.



